nonsmall cell lung cancer stage 2 treatment
Báo cáo khoa học: "Large volume unresectable locally advanced nonsmall cell lung cancer: acute toxicity and initial outcome results with rapid arc" potx
... Organization for Research and Treatment of Cancer, National Cancer Institute of the United State, National Cancer Institute of Canada. J Natl Cancer Inst 20 00, 92: 205 -21 6. 29 . Low DA, Harms WB, Mutic ... radiation treatment. No patients had acute skin toxicity. Esophageal toxicity was mild. No Grade 3 toxicity occurred. Grade 1 and Grade 2 acute esophageal toxicity occurred in 22 /24 and 2/ 24 patients respectively. ... 549 Mean [Gy] Minimize 30.4 ± 7.0 V 20 Gy [%] Minimize 52. 8 ± 8.9 Contra-lateral lung Volume [cm 3 ] - 1945 ± 517 Mean [Gy] < 15 Gy 13.7 ± 3.9 V 20 Gy [%] < 20 -30% 21 .1 ± 6.1 Spinal Cord Volume...
Ngày tải lên: 09/08/2014, 09:20
Báo cáo khoa học: " Validation of an elastic registration technique to estimate anatomical lung modification in NonSmall-Cell Lung Cancer Tomotherapy" docx
... 9.17 ± 5.46 16. 72 4 6.43 ± 2. 65 10 .24 6. 92 ± 2. 05 16. 72 elastic 2. 42 ± 0.73 3.35 4.18 ± 2. 17 7 .28 4.11 ± 2. 17 7 .20 3.57 ± 1.00 7 .28 2. rigid 6 3 .2 ± 1.60 5 .26 6 4 .2 ± 2. 19 6. 42 4 4.4 ± 4.13 10.39 ... 5 5.39 ± 2. 51 8.33 5 7.95 ± 2. 62 11.13 4 9.86 ± 5.34 14.46 7.73 ± 2. 24 14.46 elastic 3. 82 ± 2. 89 8.76 4.83 ± 3.73 11 .22 5.1 ± 2. 87 8.35 4.58 ± 0.67 11 .22 5. rigid 5 3.08 ± 1.13 4.57 4 2. 87 ± 1.38 ... 0.87 elastic -0.69 0.77 0.95 0. 62 1 .22 0.95 -0.19 0.53 0.95 2. rigid 4.44 1.43 0.90 10. 12 2.71 0.87 -2. 17 2. 82 0.71 elastic 2. 03 0.53 0.93 4.78 0.78 0.93 1.61 0. 32 0.93 3. rigid 3.33 2. 89 0.88 3.73 1.77...
Ngày tải lên: 09/08/2014, 09:20
Báo cáo hóa học: " Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer" pdf
... 69 61 57 21 7 60 SCC 1 0 7 1 12 0 LCC 5 0 4 11 0 others 3 0 2 0 0 EGFR exon 19 29 10 18 21 55 58 21 exon21 27 0 12 14 18 56 23 wild-type 22 51 29 29 6 145 167 16 IHC sensitivity overall 92% delE746-A750 ... anticancer agents. Nat Rev Cancer 20 10, 10 :24 1 -25 3. 2. Sharma SV, Bell DW, Settleman J, Haber DA: Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 20 07, 7:169-181. 3. Kosaka ... non-small -cell lung cancer. Clin Cancer Res 20 09, 15:3 023 -3 028 . 13. Motoi N, Szoke J, Riely GJ, Seshan VE, Kris MG, Rusch VW, Gerald WL, Travis WD: Lung adenocarcinoma: modification of the 20 04 WHO...
Ngày tải lên: 18/06/2014, 16:20
Báo cáo khoa học: "Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size" ppsx
... non-small -cell lung cancer. Int J Radiat Oncol Biol Phys 20 02, 52: 3 82- 389. 16. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapy in treatment of stage I non-small cell lung cancer. ... size (mm) Range (median) 12- 55 (27 ) 12, 14 15-34 (24 ) 31-55 (35) Operability Operable 40 2 27 11 Non-operable 84 0 58 26 Histology Adenocarcinoma 66 2 46 18 Squamous cell carcinoma 35 0 19 16 Unclassified ... phase II trial of medically inoperable stage I non-small -cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 20 09, 27 : 329 0- 329 6. 6. Takeda A, Sanuki N, Kunieda E,...
Ngày tải lên: 09/08/2014, 09:20
Báo cáo khoa học: "The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer" pdf
... 0.000 Once-daily 52( 74.3) 23 (17.0) Twice-daily 18 (25 .7) 1 12( 83.0) TRT technique 0.418 2D 52( 74.3) 107(79.3) 3D 18 (25 .7) 28 (20 .7) Size of TRT field (cm 3 ) # 0. 722 Median 1 32 137 Range 54 -21 0 46 -22 8 PCI ... 13(18.6) 28 (20 .7) KPS Median 80 80 0.163 Range 60-100 60-100 Weight loss>5% 0.178 Yes 21 (30.0) 29 (21 .5) No 49(70.0) 106(78.5) LDH 0.517 22 0 IU/L 35(43.1) 34(35.3) > ;22 0 IU/L 25 (26 .4) 78 (22 .6) Unknown ... in lung cancer: small -cell lung cancer (SCLC). Int J Radiat Oncol Biol Phys 20 08, 72: 327 -334. 33. Roof KS, Fidias P, Lynch TJ, Choi NC: Radiation dose intensification in limited -stage small-cell...
Ngày tải lên: 09/08/2014, 09:20
Báo cáo khoa học: " Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer" docx
... April 20 11 Accepted: 30 June 20 11 Published: 30 June 20 11 References 1. Jemal A, Siegel R, Xu J, Ward E: Cancer Statistics, 20 10. CA Cancer J Clin 20 10, 60(5) :27 7-300, Epub 20 10 Jul 7. 2. Greene ... Oligometastases, Non-Small Cell Lung Cancer Background Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality in the United States [1]. Patients with stage IV NSCLC typically ... Oncology 20 11, 6:80 http://www.ro-journal.com/content/6/1/80 Page 2 of 7 RESEARC H Open Access Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer Praveena...
Ngày tải lên: 09/08/2014, 09:20
Báo cáo khoa học: "Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study" pps
... > 18 to 22 25 > 25 to 28 Oesophagus 1 24 > 24 to 27 27 > 27 to 28 .5 Ipsilateral Brachial Plexus 1 24 > 24 to 26 27 > 27 to 29 Heart 1 24 > 24 to 26 27 > 27 to 29 Trachea ... receiving 20 Gy or more (V 20 Gy ) from a total of 22 patients with stage I tumours and 4 patients with stage 1B tumours (with PTVs of 59 cc, 85 cc, 107 cc and 108 cc). 0 25 50 75 100 125 0 4 8 12 16 20 ... (R 50% ) from a total of 22 patients with stage IA tumours and 4 patients with stage 1B tumours (with PTVs of 59 cc, 85 cc, 107 cc and 108 cc). 0 25 50 75 100 125 0 4 8 12 16 20 Type A algorithm ...
Ngày tải lên: 09/08/2014, 09:22
Báo cáo khoa học: " Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases" docx
Ngày tải lên: 09/08/2014, 10:21
báo cáo khoa học: "EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features" pptx
Ngày tải lên: 10/08/2014, 10:21
lung cancer, volume 2
... function. Mol. Cell. Biol. 15, 71 52 7160. CH01,1 -26 ,26 pgs 07 /22 / 02, 10:41 AM24 Cellular Predictive Factors in Lung Cancer 43 had stage I, 12 patients stage II, and 66 patients had stage III tumors ... expression in primary lung cancers and cell lines. Cancer Res. 55, 505–509. CH 02, 27-38,12pgs 07 /22 / 02, 10: 42 AM38 34 Kijima et al. mutations, and overexpression. In lung cancer, the prevalent ... spectrum in ARF-defi cient mice. Cancer Res. 59, 22 17 22 22. 96. Galaktionov, K., Chen, X., and Beach, D. (1996) Cdc25 cell- cycle phosphatase as a target of c-myc. Nature 3 82, 511–517. 97. Hunter,...
Ngày tải lên: 11/04/2014, 09:49
báo cáo hóa học:" Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer" docx
... (OS) (B). 0 4 8 121 620 2 428 323 6404448 52 Weeks 0 0 .2 0.4 0.6 0.8 1 TTP Patients Events (%) Arm A 35 33 (94.3) Arm B 34 32 (94.1) A 0 4 8 12 16 20 24 28 32 36 40 44 48 52 Weeks 0 0 .2 0.4 0.6 0.8 1 Survival Patients ... Estimating the world cancer burden: Globocan 20 00. Int J Cancer 20 01, 94:153-156. 2. Non-small Cell Lung Cancer Collaborative Group: Chemotherapy in non small cell lung cancer: a meta-analysis ... chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study. Cancer Chemother Pharma- col 20 07, 60: 725 -7 32. 20 . Binder D, Sailer V, Schweigert M, Temmesfeld...
Ngày tải lên: 18/06/2014, 15:20
Báo cáo hóa học: "Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins" ppt
... risk marker of lung cancer in Taiwan. Cancer 20 03, 97:1558-1563. 11. Klein F, Amin Kotb WF, Petersen I: Incidence of human papilloma virus in lung cancer. Lung Cancer 20 09, 65:13-18. 12. Zochbauer-Muller ... Molecular and genetic pathways in penile cancer. Lancet Oncol 20 07, 8: 420 - 429 . 4. Syrjänen KJ: HPV infections and oesophageal cancer. J Clin Pathol 20 02, 55: 721 - 728 . 5. Lyronis ID, Baritaki S, Bizakis ... liver carcinogenesis. Cancer Res 20 10, 70 :21 2 -22 0. 34. Puga A, Xia Y, Elferink C: Role of the aryl hydrocarbon receptor in cell cycle regulation. Chem Biol Interact 20 02, 141:117-130. 35. Chang...
Ngày tải lên: 18/06/2014, 16:20